STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System ...
Shares of Alterity Therapeutics ATHE were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for ...
Promising new research shows Alterity’s novel brain imaging tool could play a key role in diagnosing and tracking Multiple System Atrophy. Quality peer-reviewed publication highlights use of ...
At last night’s Michigan Student Assembly meeting, MSA representatives introduced three new resolutions and addressed six resolutions that were proposed at previous meetings. One of the proposals was ...
The Maryland Stadium Authority wants Baltimore City to help pay for a feasibility study on a proposed expanded convention center, new arena and hotel for downtown Baltimore. The MSA voted Tuesday to ...
A pilot study conducted by the Northern Territory Department of Primary Industry (DPIF) and Perth's Murdoch University has revealed a Meat Standards Australia (MSA) non-compliance rate of 70 per cent ...
>The summer of 2004 marked the beginning of the University’s strategic positioning to become one of the top three public research universities. At the time, this idea of transformation seemed very ...
In the future there might be more time for students to study for finals. On Tuesday, the Minnesota Student Association passed a resolution to lobby the University administration and the Board of ...
The goal is to develop a disease modifying treatment that stops or slow down the progression of alpha-synucleinopathies e.g. Parkinson's disease and MSA. BioArctic's phase 2a study EXIST with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback